Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neisseria Meningitidis (Bacterial Meningitis)”

32 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 32 results

Testing effectiveness (Phase 2)Study completedNCT03295318
What this trial is testing

Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds

Who this might be right for
Meningitis, Meningococcal
Serum Institute of India Pvt. Ltd. 375
Large-scale testing (Phase 3)UnknownNCT02858570
What this trial is testing

Conjugate Vaccine Against Meningococcus C a Brazilian Project

Who this might be right for
Serogroup C Meningococcal Meningitis
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 1,644
Large-scale testing (Phase 3)Study completedNCT02305446
What this trial is testing

Safety and Blood Donations in Adults Vaccinated With rMenB+OMV NZ.

Who this might be right for
Meningitis, Meningococcal, Serogroup B
Novartis 55
Large-scale testing (Phase 3)Study completedNCT04707391
What this trial is testing

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,250
Post-approval studies (Phase 4)Active Not RecruitingNCT06113198
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against N. Meningitidis Serogroup B Infection in Healthy Infants From 2 Months of Age

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 50
Post-approval studies (Phase 4)Study completedNCT01430611
What this trial is testing

Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children

Who this might be right for
Meningococcal DiseaseMeningitis
Sanofi Pasteur, a Sanofi Company 666
Large-scale testing (Phase 3)Study completedNCT00539032
What this trial is testing

Immunology and Safety of Menactra® in Children in Saudi Arabia

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 238
Testing effectiveness (Phase 2)Study completedNCT00772070
What this trial is testing

Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate Vaccine

Who this might be right for
MeningitisMeningococcemiaNeisseria Meningitidis
Sanofi Pasteur, a Sanofi Company 173
Early research (Phase 1)Study completedNCT00631995
What this trial is testing

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 360
Testing effectiveness (Phase 2)Study completedNCT00700713
What this trial is testing

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 181
Not applicableStudy completedNCT00161941
What this trial is testing

Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216

Who this might be right for
Meningococcal Meninigitis, Serogroup C
Pfizer 321
Not applicableStudy completedNCT03378258
What this trial is testing

Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.

Who this might be right for
Meningitis, MeningococcalMeningococcal SepsisMeningococcal Disease+3 more
Belfast Health and Social Care Trust 1,329
Post-approval studies (Phase 4)Study completedNCT00271479
What this trial is testing

Fractional Dose Tetravalent A, C, Y, W135 Meningococcal Polysaccharide Vaccine

Who this might be right for
Infections, MeningococcalMeningitis, Meningococcic
Epicentre 720
Large-scale testing (Phase 3)Study completedNCT03964012
What this trial is testing

Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)

Who this might be right for
Meningococcal Meningitis
Serum Institute of India Pvt. Ltd. 1,800
Testing effectiveness (Phase 2)Study completedNCT00269477
What this trial is testing

Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 145
Large-scale testing (Phase 3)Study completedNCT00161928
What this trial is testing

Study of NeisVac-C Vaccine to Evaluate Immunological Interference With Hepatitis B, Inactivated Polio and Acellular Pertussis Vaccines in Healthy Infants

Who this might be right for
Meningitis, Meningococcal
Pfizer 330
Testing effectiveness (Phase 2)Study completedNCT00258856
What this trial is testing

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 234
Testing effectiveness (Phase 2)Ended earlyNCT00772629
What this trial is testing

Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy Adults

Who this might be right for
MeningitisMeningococcemia
Sanofi Pasteur, a Sanofi Company 18
Post-approval studies (Phase 4)Study completedNCT04450498
What this trial is testing

Demonstrate Non-inferior Immunogenicity of Yuxi Walvax MPV ACYW® Vaccine in Healthy Subjects Aged 2-10 Years

Who this might be right for
Neisseria Meningitides Meningitis
Walvax Biotechnology Co., Ltd. 260
Large-scale testing (Phase 3)Study completedNCT00617760
What this trial is testing

Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)

Who this might be right for
Neisseria Meningitidis (Bacterial Meningitis)Invasive Pneumococcal Disease (IPD)
Pfizer 330
Next Page